Cargando…
Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review
BACKGROUND: Omalizumab is a valuable alternative treatment for allergic bronchopulmonary aspergillosis (ABPA). The effectiveness and safety of this medication have not been confirmed. The main purpose of this study was to evaluate the effectiveness and safety of omalizumab for ABPA. METHODS: This st...
Autores principales: | Cai, Cuihong, Qu, Jingjing, Zhou, Jianying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571511/ https://www.ncbi.nlm.nih.gov/pubmed/37833657 http://dx.doi.org/10.1186/s12890-023-02696-x |
Ejemplares similares
-
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Ashkenazi, Moshe, et al.
Publicado: (2018) -
Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab
por: Collins, Jennifer, et al.
Publicado: (2012) -
Steroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis
por: Beam, Keith T., et al.
Publicado: (2015) -
Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
por: da Cunha, Fernanda Sales, et al.
Publicado: (2018) -
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]
Publicado: (2018)